Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
View/ Open
Author
Stivaros, Stavros M
Alston, Robert
Nadol, Joseph B
Quesnel, Alicia
O'Malley, Jennifer
Whitfield, Gillian A
McCabe, Martin G
Freeman, Simon R
Lloyd, Simon K
Wright, Neville B
Kilday, John-Paul
Kamaly-Asl, Ian D
Mills, Samantha J
Rutherford, Scott A
King, Andrew T
Evans, D Gareth
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1136/jmedgenet-2015-103050Metadata
Show full item recordCitation
Stivaros, S. M., A. O. Stemmer-Rachamimov, R. Alston, S. R. Plotkin, J. B. Nadol, A. Quesnel, J. O'Malley, et al. 2015. “Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.” Journal of Medical Genetics 52 (8): 557-562. doi:10.1136/jmedgenet-2015-103050. http://dx.doi.org/10.1136/jmedgenet-2015-103050.Abstract
Background: Neurofibromatosis Type 2 (NF2) is a dominantly inherited tumour syndrome with a phenotype which includes bilateral vestibular (eighth cranial nerve) schwannomas. Conventional thinking suggests that these tumours originate at a single point along the superior division of the eighth nerve. Methods: High resolution MRI was performed in children genetically proven to have NF2. The superior vestibular nerve (SVN) and inferior vestibular nerve (IVN) were visualised along their course with points of tumour origin calculated as a percentage relative to the length of the nerve. Results: Out of 41 patients assessed, 7 patients had no identifiable eighth cranial nerve disease. In 16 patients there was complete filling of the internal auditory meatus by a tumour mass such that its specific neural origin could not be determined. In the remaining 18 cases, 86 discrete separate foci of tumour origin on the SVN or IVN could be identified including 23 tumours on the right SVN, 26 tumours on the right IVN, 18 tumours on the left SVN and 19 tumours on the left IVN. Discussion This study, examining the origins of vestibular schwannomas in NF2, refutes their origin as being from a single site on the transition zone of the superior division of the vestibular nerve. We hypothesise a relationship between the number of tumour foci, tumour biology and aggressiveness of disease. The development of targeted drug therapies in addition to bevacizumab are therefore essential to improve prognosis and quality of life in patients with NF2 given the shortcomings of surgery and radiation treatments when dealing with the multifocality of the disease.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518745/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:21462664
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)